Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Adverum Biotechnologies, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 118 | −13 |
| Shares | 95.1M | 10.1K | 79.2M | −15.9M (−16.7%) |
| Value | $937.9M | $100.0K | $280.4M | −$657.3M (−70.1%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 1,626,698 | $5.69M | 0.02% |
| K2 Principal Fund, L.P. | 898,307 | $3.14M | 0.35% |
| Quinn Opportunity Partners LLC | 248,004 | $868.0K | 0.05% |
| Walleye Capital LLC | 234,185 | $820.0K | 0.03% |
| Alps Advisors Inc | 128,992 | $451.0K | 0.00% |
| Virtu Financial LLC | 73,955 | $259.0K | 0.03% |
| Susquehanna Fundamental Investments, LLC | 57,180 | $200.0K | 0.00% |
| Walleye Trading LLC | 54,711 | $191.0K | 0.01% |
| Prudential Financial Inc | 51,484 | $180.0K | 0.00% |
| Acadian Asset Management LLC | 41,300 | $144.0K | 0.00% |
| Ergoteles LLC | 37,200 | $130.0K | 0.00% |
| ExodusPoint Capital Management, LP | 37,064 | $130.0K | 0.00% |
| Virginia Retirement Systems Et Al | 34,800 | $122.0K | 0.00% |
| Quantbot Technologies LP | 31,400 | $109.0K | 0.01% |
| Caxton Associates LP | 28,222 | $99.0K | 0.01% |
| Squarepoint Ops LLC | 26,807 | $94.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 15,371 | $54.0K | 0.01% |
| Lipe & Dalton | 15,000 | $52.0K | 0.03% |
| CSS LLC | 14,000 | $49.0K | 0.00% |
| Millennium Management LLC | 11,492 | $40.0K | 0.00% |
| Federated Hermes, Inc. | 442 | $2.00K | 0.00% |
| Lindbrook Capital, LLC | 410 | $1.00K | 0.00% |
Sold out (35)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| E Fund Management Co., Ltd. | 10,139 | $100.0K |